Drawing for R G + A

USPTO serial 78586709

R G + A

Reviewed by CopyMark Law Group

Reg. 3063565Status 710
Filing date
Status date
Registration date
Feb 28, 2006
Examiner
ZAK, HENRY
Law office
GENERIC WEB UPDATE

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with R G + A?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bruce Londa

Bruce Londa Norris McLaughlin, P.A.7 Times SquareNew York, NY 10036-6524UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035consulting services in the field of product pricing strategies and life-cycle assessment for the pharmaceutical industry; and developing product life-cycle assessments for the pharmaceutical industry; consulting services in the fields of product marketing and contracting strategies for the pharmaceutical industry; developing pharmaceutical contracting strategies; business consulting services, namely product value assessments for the pharmaceutical industry; business consulting services in the field of product value assessments for the pharmaceutical industry; and product value assessments for the pharmaceutical industry; market research and conducting market research studies in the fields of medicine, pharmaceuticals, and biotechnology; medical, scientific, and pharmaceutical product marketing research and marketing research methodologies; conducting marketing research studies for others; consulting services namely analyzing and reporting the drug prescription behavior of doctors in the pharmaceutical industrySECTION 8 - CANCELLEDJun 28, 2004
042product research in the fields of medicine, pharmaceuticals, and biotechnology; technical consultation in the fields of medicine, pharmaceuticals, and biotechnologySECTION 8 - CANCELLEDJun 28, 2004

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 11, 2026CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Feb 6, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 11, 2016NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Mar 11, 2016RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Mar 11, 201689AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Mar 11, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 4, 2016E89RTEAS SECTION 8 & 9 RECEIVED—
Feb 28, 2015REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Nov 26, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 26, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 16, 2011C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 16, 2011APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 28, 2011E815TEAS SECTION 8 & 15 RECEIVED—
Feb 28, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 6, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 16, 2005NPUBNOTICE OF PUBLICATION—
Oct 13, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 7, 2005ALIEASSIGNED TO LIE—
Oct 5, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 4, 2005XAECEXAMINER'S AMENDMENT ENTERED—
Oct 3, 2005GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 3, 2005CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 30, 2005GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2005DOCKASSIGNED TO EXAMINER—
Mar 18, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance